Cost Effectiveness of Nivolumab Monotherapy for the Treatment of Advanced Melanoma Patients in the United Kingdom
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.047
https://www.valueinhealthjournal.com/article/S1098-3015(16)31414-0/fulltext
Section Title :
Session VI
Section Order :
40
First Page :
A354
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)31414-0&doi=10.1016/j.jval.2016.09.047